Laura Fionda

Pubblicazioni

Titolo Pubblicato in Anno
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP NEUROLOGICAL SCIENCES 2021
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials EUROPEAN JOURNAL OF NEUROLOGY 2021
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study MUSCLE & NERVE 2021
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients AUTOIMMUNITY REVIEWS 2020
Minimal Symptom Expression' in Patients With Acetylcholine Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis Treated With Eculizumab JOURNAL OF NEUROLOGY 2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY 2020
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy NEUROLOGICAL SCIENCES 2020
Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark cores NEUROMUSCULAR DISORDERS 2020
Gender effect on cardiac involvement in myotonic dystrophy type 1 EUROPEAN JOURNAL OF NEUROLOGY 2020
Nerve high resolution ultrasonography in Tangier disease MUSCLE & NERVE 2019
Nerve high-resolution ultrasonography in peripheral nerve injuries associated with supracondylar humeral fractures in children JOURNAL OF CLINICAL NEUROSCIENCE 2019
Eculizumab improves fatigue in refractory generalized myasthenia gravis QUALITY OF LIFE RESEARCH 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis MUSCLE & NERVE 2019
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2) QUALITY OF LIFE RESEARCH 2019
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study JOURNAL OF THE NEUROLOGICAL SCIENCES 2019
Multifocal motor neuropathy following treatment with adalimumab for ulcerative colitis JOURNAL OF NEUROLOGY 2018
A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre JOURNAL OF NEUROLOGY 2018
Widening the phenotypical spectrum of EGR2-related CMT: unusual phenotype for R409W mutation CLINICAL NEUROPHYSIOLOGY 2018
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN). a phase 3, randomised, double-blind, placebo-controlled, multicentre study LANCET NEUROLOGY 2017
Marked efficacy of Rituximab in multifocal motor neuropathy associated with chronic lymphocytic leukemia OPEN JOURNAL OF CLINICAL & MEDICAL CASE REPORTS 2016

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma